Details for Luxembourg Supplementary Protection Certificate: 92692
✉ Email this page to a colleague
Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2201840 | 92692 | Luxembourg | PRODUCT NAME: IBRUTINIB, OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI. FIRST REGISTRATION: 20141023 | ⤷ Try a Trial |